Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review

Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review

Introduction Ebola virus disease is one of the most devastating infectious diseases in the world with up to 90% case fatality observed. There are at least 13 candidate vaccines developed and being tested to prevent the occurrence of the Ebola virus disease. While none of these candidate vaccines has...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Duduzile Edith Ndwandwe, Charles Shey Wiysonge, Lindi Mathebula, Elizabeth Pienaar
Format:	Artykuł
Język:	English
Wydane:	BMJ Publishing Group 2019-07-01
Seria:	BMJ Open
Dostęp online:	https://bmjopen.bmj.com/content/9/7/e029617.full

Podobne zapisy

Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data
od: Duduzile Edith Ndwandwe, i wsp.
Wydane: (2022-01-01)

Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis
od: Duduzile Edith Ndwandwe, i wsp.
Wydane: (2019-10-01)

Description of vaccine clinical trials in Africa: a narrative review
od: Duduzile Ndwandwe, i wsp.
Wydane: (2020-04-01)

Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries
od: Duduzile Ndwandwe, i wsp.
Wydane: (2022-11-01)

Randomised trials of COVID-19 vaccines in Africa – charting the path forward
od: Charles S. Wiysonge, i wsp.
Wydane: (2022-05-01)

Factors associated with HPV vaccine acceptance and hesitancy in Africa: a systematic review protocol
od: Duduzile Edith Ndwandwe, i wsp.
Wydane: (2024-11-01)

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
od: Lindi Mathebula, i wsp.
Wydane: (2022-06-01)

Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries
od: Lindi Mathebula, i wsp.
Wydane: (2023-08-01)

COVID-19 vaccine demand protest might have increased vaccine acceptance and uptake in South Africa
od: Edison Johannes Mavundza, i wsp.
Wydane: (2022-11-01)

Assessing routine childhood vaccination acceptance, hesitancy and refusal in Cape Town, Western Cape, South Africa: a mixed-method study protocol
od: Charles Shey Wiysonge, i wsp.
Wydane: (2025-02-01)

The Magnitude and Determinants of Missed Opportunities for Childhood Vaccination in South Africa
od: Duduzile Ndwandwe, i wsp.
Wydane: (2020-11-01)

Current tools available for investigating vaccine hesitancy: a scoping review protocol
od: Charles Shey Wiysonge, i wsp.
Wydane: (2019-12-01)

Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis.
od: Ameer S J Hohlfeld, i wsp.
Wydane: (2021-01-01)

Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness
od: Olatunji O. Adetokunboh, i wsp.
Wydane: (2019-11-01)

Experimental vaccine protects monkeys against Ebola virus
od: Scott Gottlieb

Contextualised strategies to increase childhood and adolescent vaccination coverage in South Africa: a mixed-methods study
od: Duduzile Edith Ndwandwe, i wsp.
Wydane: (2020-06-01)

Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
od: Charles Shey Wiysonge, i wsp.
Wydane: (2022-01-01)

The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis
od: Olatunji O. Adetokunboh, i wsp.
Wydane: (2019-11-01)

Vaccines against Ebola virus
od: Venkatraman, N, i wsp.
Wydane: (2017)

A scoping review of the impact of long-distance truck drivers on the spread of COVID-19 infection
od: Thobile Malinga, i wsp.
Wydane: (2021-01-01)

Exploring the complexity of the implementation determinants of human papillomavirus vaccination in Africa through a systems thinking lens: A rapid review
od: Abdu A. Adamu, i wsp.
Wydane: (2024-12-01)

Assessing the Implementation Determinants of Pilot Malaria Vaccination Programs in Ghana, Kenya, and Malawi through a Complexity Lens: A Rapid Review Using a Consolidated Framework for Implementation Research
od: Abdu A. Adamu, i wsp.
Wydane: (2024-01-01)

COVID-19 and the Gaping Wounds of South Africa’s Suboptimal Immunisation Coverage: An Implementation Research Imperative for Assessing and Addressing Missed Opportunities for Vaccination
od: Chukwudi A. Nnaji, i wsp.
Wydane: (2021-06-01)

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
od: Jason S Richardson, i wsp.
Wydane: (2009-01-01)

Incomplete vaccination and associated factors among children aged 12–23 months in South Africa: an analysis of the South African demographic and health survey 2016
od: Duduzile Ndwandwe, i wsp.
Wydane: (2021-01-01)

Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: a 2019 cross-sectional descriptive analysis
od: Tamara Kredo, i wsp.
Wydane: (2022-06-01)

Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review
od: Abdu A. Adamu, i wsp.
Wydane: (2024-08-01)

Multilevel Analysis of Individual and Contextual Factors Associated with Polio Non-Vaccination in Africa: Further Analyses to Enhance Policy and Opportunity to Save More Lives
od: Olalekan A. Uthman, i wsp.
Wydane: (2021-06-01)

A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
od: Yoshimi Tsuda, i wsp.
Wydane: (2011-08-01)

Country-Level Assessment of Missed Opportunities for Vaccination in South Africa: Protocol for Multilevel Analysis
od: Ndwandwe, Duduzile, i wsp.
Wydane: (2020-09-01)

Positioning implementation science in national immunization programmes to improve coverage equity and advance progress toward Immunization Agenda 2030: An urgent global health imperative
od: Abdu A. Adamu, i wsp.
Wydane: (2024-12-01)

Informal health sector and routine immunization: making the case for harnessing the potentials of patent medicine vendors for the big catch-up to reduce zero-dose children in sub-Saharan Africa
od: Abdu A. Adamu, i wsp.
Wydane: (2024-03-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
od: Andrea Marzi, i wsp.
Wydane: (2015-02-01)

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
od: Viktor Lemmens, i wsp.
Wydane: (2023-07-01)

Missed Opportunities for Vaccination and Associated Factors among Children Attending Primary Health Care Facilities in Cape Town, South Africa: A Pre-Intervention Multilevel Analysis
od: Chukwudi A. Nnaji, i wsp.
Wydane: (2022-05-01)

Reporting quality of systematic reviews of interventions aimed at improving vaccination coverage: compliance with PRISMA guidelines
od: Valantine Ngum Ndze, i wsp.
Wydane: (2019-12-01)

Estimating vaccine confidence levels among healthcare students and staff of a tertiary institution in South Africa: protocol of a cross-sectional survey
od: Charles Shey Wiysonge, i wsp.
Wydane: (2021-05-01)

In silico-based vaccine design against Ebola virus glycoprotein
od: Dash, R., i wsp.
Wydane: (2017)

In silico-based vaccine design against Ebola virus glycoprotein
od: Dash R, i wsp.
Wydane: (2017-03-01)

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease
od: Xiao-Xin Wu, i wsp.
Wydane: (2015-11-01)